Eli Historical Income Statement

LLY Stock  USD 777.96  0.22  0.03%   
Historical analysis of Eli Lilly income statement accounts such as Gross Profit of 28.9 B can show how well Eli Lilly And performed in making a profits. Evaluating Eli Lilly income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Eli Lilly's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Eli Lilly And latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Eli Lilly And is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Eli Income Statement Analysis

Eli Lilly And Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Eli Lilly shareholders. The income statement also shows Eli investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Eli Lilly Income Statement Chart

Eli Lilly And Income Statement is one of the three primary financial statements used for reporting Eli's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Eli Lilly And revenue and expense. Eli Lilly Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Eli Lilly's Discontinued Operations is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 1.6 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 994.5 M in 2024.

Total Revenue

Total revenue comprises all receipts Eli Lilly And generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Eli Lilly And minus its cost of goods sold. It is profit before Eli Lilly operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Eli Lilly And. It is also known as Eli Lilly overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Eli Lilly And operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Eli Lilly And is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most accounts from Eli Lilly's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Eli Lilly And current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Eli Lilly's Discontinued Operations is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 1.6 B in 2024, whereas Depreciation And Amortization is likely to drop slightly above 994.5 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit21.0B21.9B27.5B28.9B
Total Revenue28.3B28.5B34.1B35.8B

Eli Lilly income statement Correlations

0.670.580.520.840.320.310.430.920.540.670.080.640.110.660.490.150.08-0.23-0.410.180.090.55-0.370.37-0.2
0.670.750.740.580.690.710.760.590.680.66-0.180.640.090.390.750.410.0-0.46-0.710.330.290.67-0.850.83-0.54
0.580.751.00.710.870.840.890.660.980.62-0.510.540.290.640.980.2-0.12-0.34-0.720.160.310.5-0.620.660.0
0.520.741.00.680.910.860.890.60.980.62-0.520.540.280.620.980.23-0.15-0.32-0.710.170.290.47-0.630.67-0.01
0.840.580.710.680.440.420.50.950.730.72-0.140.610.370.850.630.030.02-0.09-0.370.050.230.34-0.290.31-0.15
0.320.690.870.910.440.90.90.340.820.62-0.510.60.050.330.90.49-0.28-0.41-0.780.330.110.49-0.730.76-0.01
0.310.710.840.860.420.90.990.370.770.4-0.740.340.240.270.860.260.09-0.49-0.750.470.450.55-0.660.690.04
0.430.760.890.890.50.90.990.470.810.47-0.690.40.230.350.890.270.09-0.5-0.770.470.430.59-0.680.710.02
0.920.590.660.60.950.340.370.470.640.63-0.110.540.320.740.580.020.07-0.26-0.440.050.30.51-0.310.33-0.11
0.540.680.980.980.730.820.770.810.640.58-0.490.490.320.740.950.08-0.11-0.2-0.590.10.270.36-0.510.550.03
0.670.660.620.620.720.620.40.470.630.580.220.960.10.570.570.58-0.4-0.15-0.540.03-0.090.51-0.60.58-0.43
0.08-0.18-0.51-0.52-0.14-0.51-0.74-0.69-0.11-0.490.220.3-0.33-0.07-0.550.24-0.360.30.33-0.36-0.56-0.080.14-0.21-0.45
0.640.640.540.540.610.60.340.40.540.490.960.3-0.180.450.50.71-0.51-0.19-0.550.09-0.30.49-0.630.6-0.43
0.110.090.290.280.370.050.240.230.320.320.1-0.33-0.180.410.23-0.470.430.150.05-0.170.790.050.14-0.090.04
0.660.390.640.620.850.330.270.350.740.740.57-0.070.450.410.51-0.220.060.32-0.05-0.040.080.02-0.010.02-0.02
0.490.750.980.980.630.90.860.890.580.950.57-0.550.50.230.510.26-0.18-0.46-0.790.160.320.52-0.690.74-0.01
0.150.410.20.230.030.490.260.270.020.080.580.240.71-0.47-0.220.26-0.7-0.4-0.620.07-0.360.52-0.710.69-0.38
0.080.0-0.12-0.150.02-0.280.090.090.07-0.11-0.4-0.36-0.510.430.06-0.18-0.70.10.330.510.53-0.090.37-0.380.15
-0.23-0.46-0.34-0.32-0.09-0.41-0.49-0.5-0.26-0.2-0.150.3-0.190.150.32-0.46-0.40.10.82-0.25-0.35-0.780.65-0.670.07
-0.41-0.71-0.72-0.71-0.37-0.78-0.75-0.77-0.44-0.59-0.540.33-0.550.05-0.05-0.79-0.620.330.82-0.2-0.27-0.850.87-0.90.15
0.180.330.160.170.050.330.470.470.050.10.03-0.360.09-0.17-0.040.160.070.51-0.25-0.20.040.29-0.140.10.14
0.090.290.310.290.230.110.450.430.30.27-0.09-0.56-0.30.790.080.32-0.360.53-0.35-0.270.040.33-0.160.2-0.05
0.550.670.50.470.340.490.550.590.510.360.51-0.080.490.050.020.520.52-0.09-0.78-0.850.290.33-0.710.7-0.19
-0.37-0.85-0.62-0.63-0.29-0.73-0.66-0.68-0.31-0.51-0.60.14-0.630.14-0.01-0.69-0.710.370.650.87-0.14-0.16-0.71-0.990.53
0.370.830.660.670.310.760.690.710.330.550.58-0.210.6-0.090.020.740.69-0.38-0.67-0.90.10.20.7-0.99-0.46
-0.2-0.540.0-0.01-0.15-0.010.040.02-0.110.03-0.43-0.45-0.430.04-0.02-0.01-0.380.150.070.150.14-0.05-0.190.53-0.46
Click cells to compare fundamentals

Eli Lilly Account Relationship Matchups

Eli Lilly income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.6B1.6B2.4B2.3B1.5B994.5M
Interest Expense400.6M359.6M339.8M331.6M312.3M327.9M
Total Revenue22.3B24.5B28.3B28.5B34.1B35.8B
Gross Profit17.6B19.1B21.0B21.9B27.5B28.9B
Other Operating Expenses16.5B17.7B20.8B20.3B23.8B12.0B
Operating Income5.0B6.1B6.4B7.1B10.3B10.8B
Ebit5.0B6.1B6.4B7.1B10.9B11.5B
Ebitda6.6B7.6B8.7B9.4B12.5B13.1B
Cost Of Revenue4.7B5.5B7.3B6.6B6.6B3.6B
Total Operating Expenses11.8B12.2B13.5B13.6B17.2B18.1B
Income Before Tax5.3B7.2B6.2B6.8B6.6B3.5B
Total Other Income Expense Net291.6M1.2B(201.6M)(320.9M)(3.8B)(3.6B)
Net Income4.6B6.2B5.6B6.2B5.2B2.7B
Income Tax Expense628M1.0B573.8M561.6M1.3B810.6M
Selling General Administrative6.2B6.1B6.4B6.4B6.9B5.7B
Research Development5.6B6.1B7.0B7.2B9.3B9.8B
Net Income Applicable To Common Shares8.3B6.2B5.6B6.2B7.2B4.0B
Net Income From Continuing Ops4.6B6.2B5.6B6.2B5.2B4.4B
Non Recurring2.8B2.5B815.2M244.6M281.3M267.2M
Non Operating Income Net Other52.4M74.8M291.6M(320.9M)(288.8M)(274.4M)
Selling And Marketing Expenses6.2B1.1B1.2B1B461.9M438.8M
Minority Interest75.7M1.1B92.2M183.6M211.1M241.8M
Tax Provision628M1.0B573.8M561.6M1.3B989.6M
Interest Income80.4M326.6M314.4M268.8M173.6M204.8M
Net Interest Income(320.2M)(326.6M)(314.4M)(268.8M)(312.3M)(327.9M)
Reconciled Depreciation1.2B1.3B1.5B1.5B1.5B1.6B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Eli Lilly And offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.13
Dividend Share
4.52
Earnings Share
5.84
Revenue Per Share
37.908
Quarterly Revenue Growth
0.281
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.